←
IASLC15,124 posts
IASLC avatar✓

IASLC ✓

@IASLC

The International Association for the Study of Lung Cancer is the only global organization dedicated solely to the study of lung cancer. #LCSM

◷ Joined July 2009▧ 5,802 Photos and videos
IASLC avatar
IASLC@IASLC·15h

⏳ One week left to submit your abstract for #TTLC27! Fellows and junior faculty: Share your research with the thoracic oncology community and help advance the conversation around targeted therapies in #lungcancer. 📅 Deadline: Nov. 23 Learn more & submit: bit.ly/4jHRxB1

Post attachment
JTO & JTO CRR avatar
⟳ IASLC retweeted
JTO & JTO CRR@JTOonline·Nov 12

@KalantriShreyas et al. sought to characterize real-world uptake of immunotherapy as standard first-line therapy for NSCLC patients with advanced disease and without actionable driver alterations. They found that race and ethnicity, insurance status, age, and comorbidity are suggested factors in the ongoing inequities in real-world delivery of this treatment. Read more on their findings here: bit.ly/4sYktHK #LungCancerResearch #LungCancer #NSCLC @uofcincycancer | @UCResearch | @uofcincy | @uofl | @UofLBCC

Post attachment
Dr Riyaz Shah avatar
⟳ IASLC retweeted
Dr Riyaz Shah@DrRiyazShah·Nov 16

Lovely analysis in Her2 mutated NSCLC demonstrating that in the absence of H2H data, on balance the TKI's have it. ADC activity maintained post TKI. TKI good in YVMA + active in non-TKD mutations. This is a very exciting space with lots happening. @IASLC jto.org/article/S1556-0864(2…

IASLC avatar
IASLC@IASLC·Nov 15

NEW! IASLC's Thoracic Oncology Multidisciplinary Simulation Series 2 is now available! Explore 4 interactive cases covering pathology, pulmonology, radiation oncology & thoracic surgery. FREE and on demand! Get started: bit.ly/4sBt2rz #IASLC #ThoracicOncology

Post attachment
IASLC avatar
IASLC@IASLC·Nov 14

Dr. Witold Rzyman explores the ongoing debate over lymph node dissection in early-stage lung cancer. 🔗 Read the full commentary in ILCN: bit.ly/4zTYrbu #LCSM

IASLC avatar
IASLC@IASLC·Nov 14

🔎 A new way to search VIKTOR! With VIKTOR 2.0, researchers can now use natural language mode to explore thoracic oncology information more intuitively. Login and discover VIKTOR's other new updates: iaslc.org/viktor

Dr. Estela Rodriguez avatar
⟳ IASLC retweeted
Dr. Estela Rodriguez@Latinamd·Nov 13

#LALCA26 @IASLC 🇧🇷 Delighted to share the podium this morning with @LuisRaezMD @mhshospital, who invited me to my very first #LATAM meeting years ago. A longtime leader in thoracic oncology, he has been instrumental in bridging the Latin American and U.S. oncology communities. Grateful for his leadership and friendship! 🫁🤝

Post attachment
JTO & JTO CRR avatar
⟳ IASLC retweeted
JTO & JTO CRR@JTOonline·Nov 13

#LDCT lung cancer screening has been an approved covered benefit for adults aged 55-77 years by the Centers for Medicare and Medicaid Services since 2015. Miller et al. sought to compare the cancer detection rates in a general population #lungcancer screening registry to the #NLST, which they found were comparable. Read the article here: bit.ly/4sObSaB #LungCancerResearch #JTO

Post attachment
IASLC avatar
IASLC@IASLC·Nov 12

Build your #research career in thoracic oncology. The IASLC Adi F. Gazdar Fellowship Grant offers $50,000 for a one-year research project. Applications close January 14. Learn more: bit.ly/47PuT2J

Post attachment